
Blood clots have been a major problem with all COVID-19 vaccines, including Pfizer and Moderna.
I have written several substack articles about those who have died from clots:
- April 30, 2023 – Blood clots – pulmonary emboli in young women – 14 cases
- April 11, 2023 – Strokes are skyrocketing in young people
- March 6, 2023 – Blood clots – young people having amputations
Those who have survived blood clots after COVID-19 vaccines are lucky to be alive but most have had a very difficult course.
Julianna was fully COVID-19 vaccinated. On Dec. 23, 2022 she developed flu like symptoms and on Jan. 1, 2023 she had two cardiac arrests, went into septic shock, multiple systemic organ failure, needing full life support.
She was diagnosed with sepsis resulting from an aggressive form of pneumonia. After weeks of fighting, she had to undergo surgery to amputate both of her legs below the knee and will lose most of her fingers.
Oct. 24, 2022 – 29 year old Krystina Pacheco suffered toxic shock syndrome after giving birth to her daughter on Oct. 24, 2022, resulting in the amputation of her hands and feet days later.
My Take…
All COVID-19 vaccines are thrombogenic (cause blood clots): Pfizer, Moderna, AstraZeneca, J&J. The latter two were taken off the market for causing blood clots.
WHO’s VigiAccess database lists 5.1 million adverse reactions to COVID-19 vaccines, including: 29751 Pulmonary Embolism, 20251 thrombosis, 20017 DVT, 18077 cerebrovascular accident, 9695 MI, 5308 Ischemic stroke, 4807 cerebral infarction, 3255 SVT, 2495 cerebral venous sinus thrombosis, 2204 venous thrombosis limb
That’s over 100,000 reported blood clot events in one adverse event reporting system. Apply an under-reporting factor of 10x or 100x and that means there are between 1 million and 10 million COVID-19 vaccinated people with blood clots.
Some of them fatal.
Dr. William Makis is a Canadian physician with expertise in Radiology, Oncology and Immunology. Governor General’s Medal, University of Toronto Scholar. Author of 100+ peer-reviewed medical publications.